Literature DB >> 8429431

Juvenile-onset mixed connective tissue disease: longitudinal follow-up.

H A Tiddens1, J J van der Net, E R de Graeff-Meeder, T J Fiselier, D J de Rooij, W H van Luijk, R Herzberger, L W van Suijlekom, W J van Venrooij, B J Zegers.   

Abstract

To establish the symptoms and clinical course of juvenile-onset mixed connective tissue disease, we studied 14 patients, classified according the criteria of Kasukawa et al. The patient records were studied retrospectively and all patients were examined in a 1-day follow-up program. Systemic lupus erythematosus and polymyositis/dermatomyositis-like symptoms disappeared in time, whereas scleroderma-like symptoms (such as in the Raynaud phenomenon) and joint abnormalities persisted. Extensive limitation of joint function was found in four patients. At the time of follow-up, no active renal disease was found. Thrombocytopenia was still present in one of the three patients who had had this feature. All patients had abnormalities of esophageal motility. Long-term corticosteroid treatment was associated with aseptic bone necrosis in three patients and growth retardation in one. We conclude that the Kasukawa criteria are easy to apply to children, and that juvenile-onset mixed connective tissue disease has many similarities to the adult form of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429431     DOI: 10.1016/s0022-3476(06)80112-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Pediatric Mixed Connective Tissue Disease.

Authors:  Roberta A Berard; Ronald M Laxer
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

2.  Fifteen-year experience of pediatric-onset mixed connective tissue disease.

Authors:  Yi-Ying Tsai; Yao-Hsu Yang; Hsin-Hui Yu; Li-Chieh Wang; Jyh-Hong Lee; Bor-Luen Chiang
Journal:  Clin Rheumatol       Date:  2009-09-16       Impact factor: 2.980

3.  Follow-up of 151 patients with high-titer U1RNP antibodies.

Authors:  P B Frandsen; N J Kriegbaum; S Ullman; M Høier-Madsen; A Wiik; P Halberg
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

4.  Altered immunoglobulin concentrations and light chain ratios in juvenile onset mixed connective tissue disease.

Authors:  A Haraldsson; H A Tiddens; T Fiselier; J A Bakkeren; C M Weemaes
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

5.  Capillaroscopy as a diagnostic tool in the diagnosis of mixed connective tissue disease (MCTD): a case report.

Authors:  Mislav Radić; Rebecca S Overbury
Journal:  BMC Rheumatol       Date:  2021-03-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.